Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
Recruiting · NCT06757153 · Registry updated 2025-01-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Early phase 1 | 2025-01-03 | NCT06757153 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhongnan Hospital | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongnan Hospital of Wuhan University | Wuhan | China | 25 |